RTP startup backed by Eshelman hits clinical milestone
A startup backed by one of North Carolina's most influential venture capitalists is moving its potential cancer treatment into a clinical study.
A startup backed by one of North Carolina's most influential venture capitalists is moving its potential cancer treatment into a clinical study.